Available Technologies

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Find technologies available for licensing from UC Davis.

Generic Method for Controlled Assembly of Molecules

Researchers at the University of California, Davis, in collaboration with researchers at IBM, have developed a widely applicable method to assemble molecules regardless of their intrinsic self-assembly properties.

Antibacterial Polypeptide with Broad-Spectrum Gram-Positive and Gram-Negative Activity

Researchers at the University of California, Davis have developed a polypeptide that kills pathogenic bacteria.

Generation of Non-Transgenic, Heritably Gene-Edited Plants

Researchers at the University of California, Davis have developed a guided nuclease based expression system to introduce genetic modifications into plants without the need for tissue culture.

One Step Process of Forming Complex Coacervation During Spray Drying

Researchers at the University of California, Davis have developed a formation of complex coacervate microparticles by spray drying.

Multiparametric Imaging with PET Scans Using High Temporal-Resolution Dynamic Data Acquisition and Modeling

Researchers at the University of California, Davis, have developed a method to acquire and model high temporal resolution (1-2 seconds per frame) dynamic data with PET scans.

Thaw Gelation Process for Encapsulating Cell Spheroids

Researchers at the University of California Davis have developed a thaw gelation process for the formation of cell spheroids within a hydrogel shell.

Inducible N-Degron Mediated Haploid Induction

Researchers at the University of California, Davis have developed a method of cell-specific degradation of centromeric proteins to induce haploid.

Osterix Specific Peptides for Treatment of Osteoporosis and Reversal of Bone Degradation

Researchers at the University of California, Davis have developed osterix-targeting peptides to prevent premature drug release during circulation, and deliver high concentration and time-depended release of drug treatments to bone defective sites.